Dr Andreas Bender
Professor for Molecular Informatics at Cambridge University
Dr Andreas Bender is a Professor for Molecular Informatics at Cambridge University, working on data analysis methods related to compound safety and efficacy, and Chief Technology & Informatics Officer (CITO) at PangeAI, part of Pangea Botanica, based in London/UK and Berlin/Germany. Previously he was a Director for Digital Life Sciences at Nuvisan in Berlin, as well as an Associate Director for Data Science and AI in the Clinical Pharmacology & Safety Sciences group at AstraZeneca. On the entrepreneurial side, Andreas was involved in setting up Healx Ltd. (for data-driven drug repurposing) and PharmEnable Ltd. (for designing novel chemistry for targets that are difficult to drug conventially), both based in Cambridge/UK. He received his PhD from the University of Cambridge and worked in the Lead Discovery Informatics group at Novartis in Cambridge/MA as well as at Leiden University in the Netherlands before his current post.
